Kathleen Lambein
- Oncology top 5%
- Molecular Biology
- Cancer Research top 5%
- Immunology top 10%
- Radiology, Nuclear Medicine and Imaging top 10%
- Co-authors
- Hannelore DenysOlivier De WeverGeert BraemsMieke Van BockstalGiuseppe FlorisRudy Van den BroeckePatrick NevenHanne Vos
- Topics
- Breast Cancer Treatment Studies (11 papers)HER2/EGFR in Cancer Research (9 papers)Monoclonal and Polyclonal Antibodies Research (6 papers)
- Cited by
- Cancer ResearchOncologyImmunology
- Partner nations
- BelgiumUnited StatesNetherlands
In The Last Decade
Kathleen Lambein
41 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Oncology 743
- Molecular Biology 578
- Cancer Research 427
- Immunology 363
- Radiology, Nuclear Medicine and Imaging 180
Countries citing papers authored by Kathleen Lambein
This map shows the geographic impact of Kathleen Lambein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen Lambein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen Lambein more than expected).
Fields of papers citing papers by Kathleen Lambein
This network shows the impact of papers produced by Kathleen Lambein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen Lambein. The network helps show where Kathleen Lambein may publish in the future.
Co-authorship network of co-authors of Kathleen Lambein
This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen Lambein. A scholar is included among the top collaborators of Kathleen Lambein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen Lambein. Kathleen Lambein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 34 | |
| 2 | A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancerbreakdown → | 442 |
| 3 | 1 | |
| 4 | 12 | |
| 5 | 16 | |
| 6 | 14 | |
| 7 | 9 | |
| 8 | 9 | |
| 9 | 116 | |
| 10 | 4 | |
| 11 | 6 | |
| 12 | 143 | |
| 13 | 4 | |
| 14 | 11 | |
| 15 | 18 | |
| 16 | Belgian guidelines for laboratory handling and pathology reporting of breast carcinoma after neoadjuvant therapy | 4 |
| 17 | 15 | |
| 18 | 3 | |
| 19 | 38 | |
| 20 | 24 |
About Kathleen Lambein
Kathleen Lambein is a scholar working on Cancer Research, Oncology and Obstetrics and Gynecology, having authored 41 papers that have together received 1.5k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (11 papers), HER2/EGFR in Cancer Research (9 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). The work is most often cited by research in Cancer Research (427 citations), Oncology (743 citations) and Immunology (363 citations). Kathleen Lambein has collaborated with scholars based in Belgium, United States and Netherlands. Frequent co-authors include Hannelore Denys, Olivier De Wever, Geert Braems, Mieke Van Bockstal, Giuseppe Floris, Rudy Van den Broecke, Patrick Neven, Hanne Vos, Ines Nevelsteen and Ann Smeets. Their work appears in journals such as Nature Medicine, Blood and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.